Psoriasis Condition Update
Communication & Creative Media (CCM) Building
375 Maple Street
Burlington, VT 05401
The New England CEPAC will convene to review ICER's condition update on therapies for plaque psoriasis. During this meeting, the Council will also review a report on elagolix for endometriosis.
Open to public comment until May 25, 2018. For more information on submitting a public comment, please visit our stakeholder engagement page.